Literature DB >> 10601056

Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

C L Sutton1, H Yang, Z Li, J I Rotter, S R Targan, J Braun.   

Abstract

BACKGROUND: Crohn's disease is a familial disorder, and antiglycan antibodies to the cell wall mannan of Saccharomyces cerevisiae (ASCA) are highly correlated with Crohn's disease. AIMS: To determine whether there is a familial pattern for expression of serum levels of anti-mannan Ig, and whether this trait is expressed in clinically unaffected Crohn's disease family members.
METHODS: 349 patients with Crohn's disease, 87 Crohn's disease affected relatives, 333 inflammatory bowel disease (IBD) free relatives, 58 spouses, and 190 healthy control patients were studied. Serum IgG and IgA binding activity to S cerevisiae cell wall mannan was quantitated by ELISA.
RESULTS: A high percentage of patients with Crohn's disease (51.9%) and affected family members (56.3%) were seropositive for anti-mannan Ig, compared with the normal control population (3.7%). Seropositive and seronegative phenotypes of Crohn's disease probands were correlated among all affected relatives, and this association was stronger in affected first degree relatives. Statistical intraclass correlations of quantitative anti-mannan Ig levels revealed significantly less variation within, rather than between families. A significant familial aggregation was observed for affected relatives; this was even stronger for unaffected relatives. While a significant familial aggregation was observed among unaffected siblings pairs, there was no significant correlation among marital pairs.
CONCLUSION: Results show that anti-mannan Ig in family members affected and unaffected with Crohn's disease is a familial trait for both affected and unaffected relatives. The lack of concordance in marital pairs indicates that familiality is due in part to a genetic factor or childhood environmental exposure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10601056      PMCID: PMC1727768          DOI: 10.1136/gut.46.1.58

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  48 in total

1.  Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers.

Authors:  H H Herfarth; S P Mohanty; H C Rath; S Tonkonogy; R B Sartor
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

2.  Distinct associations of HLA class II genes with inflammatory bowel disease.

Authors:  H Toyoda; S J Wang; H Y Yang; A Redford; D Magalong; D Tyan; C K McElree; S R Pressman; F Shanahan; S R Targan
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

3.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

Authors:  H Yang; C McElree; M P Roth; F Shanahan; S R Targan; J I Rotter
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

4.  Sibling and parent--offspring correlation estimation with variable family size.

Authors:  S Karlin; E C Cameron; P T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  In vivo insulin action is familial characteristic in nondiabetic Pima Indians.

Authors:  S Lillioja; D M Mott; J K Zawadzki; A A Young; W G Abbott; W C Knowler; P H Bennett; P Moll; C Bogardus
Journal:  Diabetes       Date:  1987-11       Impact factor: 9.461

6.  T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment.

Authors:  L Dianda; A M Hanby; N A Wright; A Sebesteny; A C Hayday; M J Owen
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

7.  Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease.

Authors:  P Knoflach; B H Park; R Cunningham; M M Weiser; B Albini
Journal:  Gastroenterology       Date:  1987-02       Impact factor: 22.682

8.  Geographic origins of Jewish patients with inflammatory bowel disease.

Authors:  M P Roth; G M Petersen; C McElree; E Feldman; J I Rotter
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

9.  Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.

Authors:  D Hollander; C M Vadheim; E Brettholz; G M Petersen; T Delahunty; J I Rotter
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

10.  An in-depth study of Crohn's disease in two French families.

Authors:  H J Van Kruiningen; J F Colombel; R W Cartun; R H Whitlock; M Koopmans; H O Kangro; J A Hoogkamp-Korstanje; M Lecomte-Houcke; M Devred; J C Paris
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

View more
  38 in total

Review 1.  Diagnostic methodologies: serology, endoscopy, and radiology.

Authors:  T Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 2.  A perspective on inflammatory bowel disease in the child and adolescent at the turn of the millennium.

Authors:  C Haller; J Markowitz
Journal:  Curr Gastroenterol Rep       Date:  2001-06

Review 3.  Recent advances in the diagnosis and classification of inflammatory bowel disease.

Authors:  Eric Vasiliauskas
Journal:  Curr Gastroenterol Rep       Date:  2003-12

4.  Frequency and significance of antibodies to Saccharomyces cerevisiae in autoimmune hepatitis.

Authors:  Albert J Czaja; Zakera Shums; Peter T Donaldson; Gary L Norman
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

5.  Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.

Authors:  M S Buckland; M Mylonaki; D Rampton; H J Longhurst
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

6.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Authors:  J Halfvarson; A Standaert-Vitse; G Järnerot; B Sendid; T Jouault; L Bodin; A Duhamel; J F Colombel; C Tysk; D Poulain
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

7.  CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.

Authors:  B Vander Cruyssen; H Peeters; I E A Hoffman; D Laukens; P Coucke; D Marichal; C Cuvelier; E Remaut; E M Veys; H Mielants; M De Vos; F De Keyser
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 8.  Immunogenetic phenotypes in inflammatory bowel disease.

Authors:  Marla-C Dubinsky; Kent Taylor; Stephan-R Targan; Jerome-I Rotter
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

9.  Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.

Authors:  Sandra S Wright; Anna Trauernicht; Erin Bonkowski; Courtney A McCall; Elizabeth A Maier; Ramona Bezold; Kathleen Lake; Claudia Chalk; Bruce C Trapnell; Mi-Ok Kim; Subra Kugathasan; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-05       Impact factor: 2.839

10.  High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study.

Authors:  William S Mow; Carol J Landers; A Hillary Steinhart; Brian G Feagan; Ken Croitoru; Ernest Seidman; Gordon R Greenberg; Stephan R Targan
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.